AI Verdict
NEUP has stronger fundamentals based on our AI analysis.
NEWH vs NEUP Fundamental Comparison
| Metric | NEWH | NEUP |
|---|---|---|
| Revenue | N/A | $15.6M |
| Net Income | $-2.8M | $-8.0M |
| Net Margin | N/A | -51.4% |
| ROE | N/A | -27.1% |
| ROA | -195.1% | -22.0% |
| Current Ratio | 147.45x | 9.04x |
| Debt/Equity | N/A | 0.00x |
| EPS | $0.00 | $-2.66 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NEWH vs NEUP: Frequently Asked Questions
Is NEWH or NEUP a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NEUP has stronger fundamentals. NEWH is rated STRONG SELL (95% confidence) while NEUP is rated SELL (68% confidence). This is not investment advice.
How does NEWH compare to NEUP fundamentally?
NewHydrogen, Inc. has ROE of N/A vs Neuphoria Therapeutics Inc.'s -27.1%. Net margins are N/A vs -51.4% respectively.
Which stock pays higher dividends, NEWH or NEUP?
NEWH has a dividend yield of N/A or no dividend while NEUP has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NEWH or NEUP for long term?
For long-term investing, consider that NEWH has STRONG SELL rating with 95% confidence, while NEUP has SELL rating with 68% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NEWH vs NEUP?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NEWH vs NEUP, the AI consensus favors NEUP based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.